 |
|
UCLA researchers develop T-cells from human embryonic stem cells
July 05, 2006Researchers from the UCLA AIDS Institute and the Institute for Stem Cell Biology and Medicine have demonstrated for the first time that human embryonic stem cells can be genetically manipulated and coaxed to develop into mature T-cells, raising hopes for a gene therapy to combat AIDS.
The study, to be published the week of July 3 in the online edition of the Proceedings of the National Academy of Sciences, found that it is possible to convert human embryonic stem cells into blood-forming stem cells that in turn can differentiate into the helper T-cells that HIV specifically targets. T-cells are one of the body's main defenses against disease.
The results mark the first time that scientists have been able to derive T-cells out of human embryonic stem cells, said Zoran Galic, assistant research biologist, and lead researcher on the study.
"This tells you that you may be able to use human embryonic stem cells to treat T cell and other blood diseases. This could be a very important weapon in the fight against AIDS," Galic said.
The study is available at http://www.pnas.org/papbyrecent.shtml
In their study, the researchers cultured human embryonic stem cells, which were incubated on mouse bone marrow support cells, which in turn converted them into blood forming cells. Those cells were then injected into a human thymus gland that had been implanted in a mouse, and the thymus then changed those blood-forming cells into T-cells. Located just above the heart in humans, the thymus is the organ where T-cells develop. It gradually shrinks in adults, weakening the immune system over time.
These results indicate that it is possible to decipher the signals that control the development of embryonic stem cells into mature T-cells, said study co-author Jerome Zack, associate director of the UCLA AIDS Institute, and professor of medicine and of microbiology,
immunology and molecular genetics at the David Geffen School of Medicine at UCLA.
"That way we can eventually repopulate the immune system in patients needing T-cells," Zack said.
This in turn could give rise to gene therapy approaches to treat other diseases involving T-cells. In addition to HIV, for instance, the technique could be used to treat severe combined immunodeficiency, or the "bubble boy disease," which leaves its victims without a working immune system, forcing them to a life in an antiseptic, germ-free environment.
University of California—Los Angeles
"This tells you that you may be able to use human embryonic stem cells to treat T cell and other blood diseases. This could be a very important weapon in the fight against AIDS," Galic said.
The study is available at http://www.pnas.org/papbyrecent.shtml
In their study, the researchers cultured human embryonic stem cells, which were incubated on mouse bone marrow support cells, which in turn converted them into blood forming cells. Those cells were then injected into a human thymus gland that had been implanted in a mouse, and the thymus then changed those blood-forming cells into T-cells. Located just above the heart in humans, the thymus is the organ where T-cells develop. It gradually shrinks in adults, weakening the immune system over time.
These results indicate that it is possible to decipher the signals that control the development of embryonic stem cells into mature T-cells, said study co-author Jerome Zack, associate director of the UCLA AIDS Institute, and professor of medicine and of microbiology,
immunology and molecular genetics at the David Geffen School of Medicine at UCLA.
"That way we can eventually repopulate the immune system in patients needing T-cells," Zack said.
This in turn could give rise to gene therapy approaches to treat other diseases involving T-cells. In addition to HIV, for instance, the technique could be used to treat severe combined immunodeficiency, or the "bubble boy disease," which leaves its victims without a working immune system, forcing them to a life in an antiseptic, germ-free environment.
University of California—Los Angeles
T-cells Current Events and T-cells News RSSHow to fortify the immunity of HIV patients
New findings from a Université de Montréal and the Vaccine and Gene Therapy Institute of Florida (VGTI) study, in collaboration with scientists from the NIH and the McGill University Health Center, may soon lead to an expansion of the drug arsenal used to fight HIV.
Periodontal pathogens enhance HIV-1 promoter activation in T cells
Today, during the 39th Annual Meeting of the American Association for Dental Research, convening at the Walter E. Washington Convention Center in Washington, DC, lead researcher O.A. Gonzalez (University of Kentucky, Lexington) will present a poster of a study titled "TLR2 and TLR9 Activation by Periodontal Pathogens induce HIV-1 Reactivation."
Test could predict which idiopathic pulmonary fibrosis patients will become severely ill
A simple blood test could predict which patients with the lung-scarring disease known as idiopathic pulmonary fibrosis (IPF) are soon to get far worse, an indicator that could one day influence their treatment, according to researchers at the University of Pittsburgh School of Medicine.
Notre Dame study focuses on protein dynamics
A discovery by associate professor of chemistry and biochemistry Brian Baker and his research group at the University of Notre Dame reveals the importance of dynamic motion by proteins involved in the body's immune response.
Herpes medication does not reduce risk of HIV transmission, UW-led international study finds
A five-year international multi-center clinical trial has found that acyclovir, a drug widely used as a safe and effective treatment taken twice daily to suppress herpes simplex virus-2 (HSV-2), which is the most common cause of genital herpes, does not reduce the risk of HIV transmission when taken by people infected with both HIV and HSV-2.
Immune therapy can protect against or treat later lymphoma
Specially developed immune system cells that target the common Epstein-Barr virus can protect immune-suppressed bone marrow transplant recipients against lymph system disease and cancers that arise from the viral infection.
Earlier flu viruses provided some immunity to current H1N1 influenza, study shows
University of California, Davis, researchers studying the 2009 H1N1 influenza virus, formerly referred to as "swine flu," have identified a group of immunologically important sites on the virus that are also present in seasonal flu viruses that have been circulating for years.
Strategy for mismatched stem cell transplants triggers protection against graft-vs.-host disease
A new technique being tested in stem-cell transplants from imperfectly matched donors has revealed a striking, unforeseen response that can suppress graft-versus-host disease, a common and dangerous complication of mismatched transplants, report scientists from Dana-Farber Cancer Institute.
UBC researchers identify key behavior of immune response to Listeria
A team of University of British Columbia microbiologists has identified a key defence mechanism used by the immune system against Listeria with strong implications for the future development of vaccines.
Pitt researchers net $5 million from NIH to explore better ways to grow cells for regenerative medicine
Regenerative medicine researchers at the University of Pittsburgh received two grants totaling more than $5 million from the National Institutes of Health (NIH) to explore new methods for cultivating replacement cells from existing tissues and organs.
More T-cells Current Events and T-cells News Articles
 |
Technical Concepts - T-Cell Preference Pack by Technical Concepts The TCellTM refills contain Microtrans®, a true odor neutralizer. TC® refills contain only the highest quality essential oils to reinforce the cleanliness of the washroom and image of the facility. They are available in a wide range of customer preferred fragrances from mild to intense for a clean, fresh scent that lasts. Contains: 1 refill each of Wakening Spring,Polar Mist, Blue Splash, Citrus and Crystal Breeze. 5 refills per pack |
 |
How to Lead a Great Cell Group Meeting.. . So People Want to Come Back by Joel Comiskey (Author), Joel (Author), T. Comiskey (Author), Joel, T. Comiskey (Author) |
 |
Samsung T509 GSM Unlocked Cell Phone with Bluetooth and Camera (Silver) by Samsung Electronics Samsung T509 Unlocked GSM Cell Phone The SGH-t509 deserves to have its own adjective, slicksleek. It embodies a range of technology that¿s every bit as up-to-the- minute as its beautiful exterior. Here's the latest contender in the race to build the thinnest, most stylish phone on the planet. In fact, the Samsung t509 is one of the skinniest phones money can buy, measuring just .39 inches thick, or 10 millimeters. Amazingly, this phone also happens to pack a lot of features into its svelte frame, including Bluetooth, a VGA camera, support for EDGE high speed data, a speakerphone, and more. Design One look at this phone and you'll wonder where the phone went. The design is simple, refined, and--once again--thin. The numeric keypad resides below a circular five-way control toggle that... |
 |
Thinkpad T60 Series 6-Cell Li-ion Battery by Lenovo Power your system whenever and wherever you need it with the ThinkPad T60 Series 6 Cell Li-Ion Battery. This rechargeable system battery delivers up to 5.8 hours of system run time. It can replace your original system battery or be swapped in as a spare. |
 |
Replacement T-CELL-15 for Electronic Chlorine Generator by Goldline Controls a Hayward Company The Turbo Cell is used with the Aqua RiteTM electronic chlorinator, Aqua Trol® above-ground pool automation control, or the the Aqua Logic® in-ground pool/spa automation control to generate fresh, pure chlorine to meet the pools sanitization needs. The Turbo Cell installs vertically or horizontally in the return pipe to the pool. Whenever the filter pump is operating, the Turbo Cell converts a low concentration of salt into chlorine which is then evenly dispersed throughout the pool via the return jets. (Generates up to 1.45 lb./.66 kg of chlorine) |
 |
Ampro T23920 2 LED Emergency Cell Phone Charger with 2 LED Flashlight by Ampro |
 |
Garmin nüvi 1260/1260T 3.5-Inch Bluetooth Portable GPS Navigator with Traffic by Garmin The Nuvi 1200 features an ultra-slim design (approximately 25% thinner than previous models), an enhanced user interface, ecoRoute, public transit mode and text-to-speech. The n vi 1200 also offers pedestrian navigation capability enabled through optional CityXplorer maps. CityXplorer maps are available for select tourist destinations in North America and Europe and can easily be downloaded directly to the n vi. The n vi's enhanced user interface features improved graphics and a new slide control for menu operation, while ecoRoute suggests fuel-efficient routes to save drivers money and fuel. Also, Garmin's new public transit mode allows you to navigate using buses, tramway, metro and suburban rail systems! Public transit - navigate using buses, tramway, metro and suburban rail systems... |
 |
PUMA Men's Cell L.I.F.T. Trainer Sneaker,Black/Silver/Red,9 D by PUMA |
 |
AT&T DECT 6.0 Digital Bluetooth Cordless Expansion Handset (TL90078) by Vtech AT&T DECT 6.0 Digital Bluetooth Cordless Expansion Handset |
|
T&E Cr2016 Lithium Coin Cell Remote / Watch Battery (Pack of 5 Batteries) by T & E |
| © 2010 BrightSurf.com |